Skip to main content
Scott Dessain, MD, Hematology, Wynnewood, PA, Lankenau Medical Center

ScottK.DessainMD

Hematology Wynnewood, PA

Physician

Dr. Dessain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dessain's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
  • Yale School of Medicine
    Yale School of MedicineClass of 1994

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2002 - 2024
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization
    InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine CharacterizationJuly 1st, 2021
  • Multiplexed, Microscale, Microarray-Based Serological Assay for Antibodies Against All Human-Relevant Coronaviruses
    Multiplexed, Microscale, Microarray-Based Serological Assay for Antibodies Against All Human-Relevant CoronavirusesFebruary 25th, 2021
  • Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
    Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19July 28th, 2020
  • Join now to see all

Grant Support

  • Human Monoclonal Antibodies That Bind Botulinum ToxinsNational Institute Of Allergy And Infectious Diseases2007–2012
  • Human Monoclonal Antibodies That Bind Botulinum ToxinsNational Institute Of Allergy And Infectious Diseases2006–2007
  • Progression Of Chronic Myelogenous LeukemiaNational Heart, Lung, And Blood Institute2002–2004
  • Progression Of Chronic Myelogenous LeukemiaNational Heart, Lung, And Blood Institute2000–2002

Hospital Affiliations